<DOC>
	<DOC>NCT00492479</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.</brief_summary>
	<brief_title>An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging</brief_title>
	<detailed_description />
	<mesh_term>Kinetin</mesh_term>
	<criteria>Female patients 3555 years of age with at least moderate signs of facial aging Written informed consent Likely to complete all study visits and follow study protocol Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements Known hypersensitivity to any study product or their components Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures) Prior use of antiaging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments) Planned facial procedures during the study (microdermabrasion, facials, etc) o Botox and fillers cannot be used during the trial or for 3 months prior to study entry Recent (within 60 days) or concurrent participation in another clinical trial Concomitant topical or systemic therapy that my interfere with study measurements or outcomes Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study Wearing of cosmetics during study visits</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>